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Letter to the Editor
Correcting an unintentional injustice: a comment
on the doctorate thesis ‘Transfusion’ by José
inCarvalho Tolentino presented
Dear Editor,
In 2005, my esteemed professors, Pedro Clóvis Junqueira and
Jacob Rosenblit, and I published, in this journal, a very thor-
ough article on the history of hemotherapy in Brazil.1 But
unfortunately,wemade ahistoricmistake in the article,which
I aim about to correct here.
We ﬁrst learned of this mistake eight years later, when Dr.
Rodrigo Falconi, a scholar of the History of Medicine, called
me. In our article, we cited a study by José Vieira deMarcondes,
presented to the Medical School of Rio de Janeiro on Septem-
ber 27, 1879, as the ﬁrst ever thesis on hemotherapy in Brazil.
Falconi read our article and, through his research, discovered
a thesis about transfusion by Dr. José de Carvalho Tolentino,
presented in the same Medical School on August 28, 1878, one
year earlier.2
The thesis by Marcondes, son of the Baron and Baroness
of Taubaté, had been rejected by the Medical School for being
too controversial. The author had then defended his thesis
at the Medical School of Bahia, on December 30, 1879.3 Mar-
condes’ thesis described some empirical experiments in blood
transfusion that had been conducted up to that time, and dis-
cussed whether the best type of transfusion would be from
animals to humans or from humans to humans. The interest-
ing aspect of the study was its detailed description of an acute
hemolytic reaction with renal abnormalities and the presence
of hemoglobin in the urine. Tolentino’s thesis, presented one
year earlier, also discussed similar aspects, which probably
served as the basis for Marcondes’ thesis.
Tolentino,2 in the ﬁrst part of his thesis, gives a historical
summary of blood transfusion organized in three eras: the ﬁrst
gives the occasional descriptions from the times of the ancient
Egyptians, through the ﬁfteenth century and then up to 1667.
These are descriptions of the ingestion of blood and the col-
lection and intravenous administration of blood from humans
and animals. These early descriptions also mentioned the
occurrence of air embolism. The second era, from 1668 to
1818, was one of total discrediting of transfusion practices,1878
and transfusions were practically abandoned. The third, truly
scientiﬁc era, began in 1818 with James Blundell. Called to
examine a woman with uterine bleeding, he saw the patient
die within a few hours. Moved by this experience, he began
to conduct numerous experiments between 1818 and 1827
and reached the conclusion that transfusion could sometimes
be of use. Tolentino cites other scientists who had studied
transfusions in animals and humans, such as Prévost, Dumas,
Milne-Edwards, Dieffenback and Bischoff. From these reports
comes the recommendation for pre-transfusion deﬁbrination,
and cooling of the syringe or pot used in the procedure.
Tolentino cites other great physicians who were starting to
recommend transfusions, highlighting a publication in the Rio
de Janeiro Medical Journal from July 31, 1877: this was the ﬁrst
Brazilian reference on the subject. The author was Dr. Felício
dos Santos, who attributed the failure of one transfusion to
the fact that the patient was already close to death.
In the second part of his thesis, in Chapter I, Tolentino2
describes the physiology of blood and its composition of
plasma, red and white cells, but his description shows that
little was known at that time about coagulation. The author
discusses deﬁbrination of the blood, and its advantages and
disadvantages. In this part of the thesis, he gives an interest-
ing statistical report: of 174 observations of transfusions made
with whole blood, 95 resulted in cures and 79 in deaths, i.e.
a mortality rate of 45%. On the other hand, with deﬁbrinated
blood transfusions, 76 transfusions resulted in 53 fatalities and
23 cures, i.e. amortality rate of 69%. The author concluded that
there were highly-regarded professionals advocating both for
and against deﬁbrinated blood, and that he preferred not to
take part in the discussion.
In Chapter II, Tolentino described successful cases of blood
transfusion: successes and failures of experimental transfu-
sions between different classes of animals, between different
animal species of the same animal group, and between dif-
ferent animals of the same species; transfusions of human
blood into the blood vessels of animals, and from ani-
mals to humans, and ﬁnally human-to-human transfusion
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xperiments, with higher chances of success. Tolentino
efended the use of arterial blood, but at the same time, he
escribes the difﬁculties of its use in humans. The author pre-
erred to use blood taken from men, as they have a higher
mount of red blood cells than women, and the blood used
hould preferably be from strong, healthy individuals aged
etween 20 and 40 years old. He advocated that 30–700mL of
lood should be collected and chilled prior to transfusion in
rder to reduce clotting time, and he suggested the addition
f anticoagulants, but concludes that the substances thatwere
vailable at the time had not been recommended for human
se. Transfusion devices should be made of glass or silver, so
s not to interfere with clotting. As for the blood components,
n this part of the thesis, Tolentino2 describes the importance
f red blood cells, which would give vitality and beneﬁts to
ying individuals.
In the third part of his thesis, Tolentino2 gave a very inter-
sting report on the indications and contraindications of blood
ransfusions as summarized below.
Indications:
Bleeding of traumatic nature
Passive or spontaneous bleeding
Constitutional bleeding (hemorrhagic diathesis)
Before major surgery
Anemia
Fainting
Malarial cachexia
Inaction
Apparent deaths (syncope by hemorrhage, shock)
Poisoning
Asphyxia
Agony
Nerve diseases
Organic diseases
The circumstances among which transfusions should not
e used, according to Tolentino,2 were:
Hypervolemia: in heart and lung disease, particularly
hemoptysis
Chronic inﬂammation of the brain, in which the softened
capillaries may rupture with the input of transfused blood
Changes in the nervous centers (because one patient
developed what they called a “shaking palsy”, with tonic
contractions of the limbs, convulsive vomiting, coma,
increased temperature and death in 4h)
Kidney disease
Tolentino2 dedicated the fourth part of his thesis to practi-
al considerations about blood transfusions:
The dilemma of “when” to transfuse: during hemorrhage?
Or should the physician wait till the hemorrhage has slowed
down, avoiding the acute phase, and expecting the patient
to recover with other measures? The author concludes that
we must resort to transfusion whenever the futility of all
other therapeutic resources employed is evident; where
there is a presumption that the patient can withstand the
transfusion; andwhen the transfusionwasnot indicated too
late.
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- The author suggests that large, surface vessels should be
used for phlebotomy, and that an assistant should hold
the limb in which the transfusion is running, observing
the pulse. If the pulse is close to normal, the transfu-
sion should be interrupted or reduced in speed. Tolentino
advised that the physician should be cautious during the
post-transfusion period too, indicating rest, stimulating
drinks, tonics and easily digestible foods. The physician
should also take steps to prevent complications such as
blood clotting, air embolism and phlebitis.
- Finally, the text describes the principles to be considered
and apparatuses to be used in transfusions. The author
postulates that the apparatuses must be kept in a perfect
state of cleanliness; they must have the capacity to contain
the required amount of blood to be transfused; that they
be easy to handle and accurate; allow the desired tempera-
ture to be maintained, and ensure that air bubbles cannot
be introduced into the veins. The author recommends the
following devices: the Moncoq-Mathieu apparatus, the M.
Belina, the Collin, and the deﬁbrination chamber.
Tolentino’s descriptions of the transfusion practices of his
day reveal some important observations. Firstly, at that time,
it was already possible to conclude that transfusion between
humans was the most appropriate form, and that the initial
concerns with air embolism, ﬂuid overload, anticoagulation
and storage of blood were emerging. A manual was published
giving the indications and contraindications of blood trans-
fusions. An important aspect of that era was the practice of
clinical hematology and transfusion medicine: the hemother-
apist was recognized as being directly involved in the care of
the patient.
Nowadays, we can control most of the adverse effects of
transfusions, we have knowledge of hundreds of blood groups,
and are able to properly identify the blood and its components.
We have quality programs, accreditations and audit commit-
tees, we have machines that separate blood into components,
and we can perform cell therapy. It is amazing how far we have
come in 136 years!
I hope that our descendants, 136 years from now, when
they read our theses on hemotherapy, will be able to compare
them with the new era of recombinant blood substitutes that
do not pose a risk to the recipient’s health, and will appreciate
the efforts made by their ancestors in the search for better
practices in medicine.
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